Company: GIFLF
Filing Date: 2025-05-12
Form Type: 6-K
Source: 0001104659-25-047168
Chunk: 19

Company: Grifols SA
Filing Date: 2025-05-12
Form: 6-K
Chunk 19
---
 1,889 21,673 10,095 33,656 2,326 Transaction costs 7,466 9,306 7,882 16,145 40,798 15,318 Impairments 3,850 24,265 787 - 28,902 - Biotest Next Level Project 6,738 7,340 5,113 4,922 24,114 16,798 SRAAS One-off - - - (5,618) (5,618) - Other non-recurring items 1,817 1,155 1,245 1,613 5,830 6,020 Total adjustments 19,872 43,954 36,700 27,157 127,682 40,461 Adjusted EBITDA 400,479 525,944 462,098 440,788 1,829,308 350,402 % Net revenue 22.4% 26.6% 25.8% 24.2% 24.8% 21.6% Q1 2024Q1 2025 Q2 2024 Q1 2025 LTMQ3 2024Q4 2024 Depreciation & Amortization OPERATING RESULT (EBIT)

- 27 - Q1 2025 Results Leverage Ratio as per Credit Agreement Business Performance Financials Final Remarks Annex In millions of euros except ratio. Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Non-Current Financial Liabilities 9,390 9,491 8,836 8,752 9,650 Non-recurrent Lease Liabilities (IFRS16) (1,026) (1,025) (969) (1,025) (1,026) Current Financial Liabilities 657 676 1,017 2,757 1,745 Recurrent Lease Liabilities (IFRS16) (119) (117) (111) (109) (111) Cash and Cash Equivalents (753) (980) (645) (2,113) (449) Net Financial Debt as per Credit Agreement 8,149 8,046 8,128 8,262 9,811 In millions of euros except ratio. LTM Q1'25 LTM Q4'24 LTM Q3'24 LTM